1. Yuan, Ming, Zhang, Chi, Chen, Shaopeng, Wu, Xianrui, Lan, Ping. 2024. PDP1 promotes KRAS mutant colorectal cancer progression by serving as a scaffold for BRAF and MEK1. In Cancer letters, 597, 217007. doi:10.1016/j.canlet.2024.217007. https://pubmed.ncbi.nlm.nih.gov/38849010/
2. Kamada, Rui, Kudoh, Fuki, Ito, Shogo, Omichinski, James G, Sakaguchi, Kazuyasu. 2020. Metal-dependent Ser/Thr protein phosphatase PPM family: Evolution, structures, diseases and inhibitors. In Pharmacology & therapeutics, 215, 107622. doi:10.1016/j.pharmthera.2020.107622. https://pubmed.ncbi.nlm.nih.gov/32650009/
3. Karagiota, Angeliki, Kanoura, Amalia, Paraskeva, Efrosyni, Simos, George, Chachami, Georgia. 2022. Pyruvate dehydrogenase phosphatase 1 (PDP1) stimulates HIF activity by supporting histone acetylation under hypoxia. In The FEBS journal, 290, 2165-2179. doi:10.1111/febs.16694. https://pubmed.ncbi.nlm.nih.gov/36453802/
4. Wang, Yufeng, Dang, Huifen, Qiao, Hui, Tian, Yinxia, Guan, Quanlin. . PDP1 promotes the progression of breast cancer through STAT3 pathway. In Cell biochemistry and function, 42, e3994. doi:10.1002/cbf.3994. https://pubmed.ncbi.nlm.nih.gov/38566355/
5. Song, Yan, Zhang, Juan, Zhang, Lei, Zhang, Suxia, Shen, Chengcheng. 2022. PDP1 Promotes Cell Malignant Behavior and Is Associated with Worse Clinical Features in Ovarian Cancer Patients: Evidence from Bioinformatics and In Vitro Level. In Computational and mathematical methods in medicine, 2022, 7397250. doi:10.1155/2022/7397250. https://pubmed.ncbi.nlm.nih.gov/36276992/